166 related articles for article (PubMed ID: 34537951)
1. Clinical Efficacy of Conservative Treatment with Micronized Purified Flavonoid Fraction in Female Patients with Pelvic Congestion Syndrome.
Akhmetzianov RV; Bredikhin RA
Pain Ther; 2021 Dec; 10(2):1567-1578. PubMed ID: 34537951
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
Kakkos SK; Nicolaides AN
Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
[TBL] [Abstract][Full Text] [Related]
3. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease.
Mezalek ZT; Feodor T; Chernukha L; Chen Z; Rueda A; Sánchez IE; Ochoa AJG; Chirol J; Blanc-Guillemaud V; Lohier-Durel C; Ulloa JH
Adv Ther; 2023 Nov; 40(11):5016-5036. PubMed ID: 37728696
[TBL] [Abstract][Full Text] [Related]
4. [Comparative efficacy of various methods of treatment of chronic venous oedema in real clinical practice].
Bogachev VI; Boldin BV; Turkin PI; Samenkov AI;
Angiol Sosud Khir; 2021; 27(3):77-83. PubMed ID: 34528591
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of micronized purified flavonoid fraction for the treatment of concomitant varicose veins of the pelvis and lower extremities.
Gavrilov SG; Moskalenko YP; Karalkin AV
Curr Med Res Opin; 2019 Jun; 35(6):1019-1026. PubMed ID: 30468077
[TBL] [Abstract][Full Text] [Related]
6. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1.
Bogachev VY; Boldin BV; Turkin PY
Adv Ther; 2018 Jul; 35(7):1001-1008. PubMed ID: 29949043
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of micronized purified flavonoid fraction in treatment of chronic venous oedema].
Bogachev VI; Boldin BV; Turkin PI; Samenkov AI
Angiol Sosud Khir; 2020; 26(2):86-94. PubMed ID: 32597888
[TBL] [Abstract][Full Text] [Related]
8. Secondary Varicose Small Pelvic Veins and Their Treatment with Micronized Purified Flavonoid Fraction.
Tsukanov YT; Tsukanov AY; Levdanskiy EG
Int J Angiol; 2016 Jun; 25(2):121-7. PubMed ID: 27231429
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of MPFF 1000 mg oral suspension on CVD C0s-C1-related symptoms and quality of life.
Maggioli A; Carpentier P
Int Angiol; 2019 Apr; 38(2):83-89. PubMed ID: 31056892
[TBL] [Abstract][Full Text] [Related]
10. Micronized purified flavonoid fraction-based conservative treatment of chronic venous disease in a real-world setting.
Bogachev V; Boldin B; Turkin P; Samenkov A; Dzhenina O
Future Cardiol; 2022 Sep; 18(10):777-785. PubMed ID: 36004765
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Micronized Purified Flavonoid Fraction-Based Venoactive Therapy After Endovenous Mechanochemical Obliteration: Prospective Comparative Study.
Khryshchanovich VY; Nebylitsin YS; Kosinets VA
Drugs Real World Outcomes; 2021 Sep; 8(3):349-358. PubMed ID: 33913099
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of two micronized purified flavonoid fraction dosing regimens in the pelvic venous pain relief.
Gavrilov SG; Karalkin AV; Moskalenko YP; Grishenkova AS
Int Angiol; 2021 Jun; 40(3):180-186. PubMed ID: 33634687
[TBL] [Abstract][Full Text] [Related]
13. MPFF 1000 mg chewable once daily vs. MPFF 500 mg twice daily in chronic venous disease: the double-blind, randomized, non-inferiority CHEWY trial.
Mansilha A; Caldevilla H; Puskás A; Lucien A; Roby L; Kirienko A
Int Angiol; 2022 Dec; 41(6):464-475. PubMed ID: 36598370
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial.
Rabe E; Agus GB; Roztocil K
Int Angiol; 2015 Oct; 34(5):428-36. PubMed ID: 25972136
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial.
Carpentier P; van Bellen B; Karetova D; Hanafiah H; Enriquez-Vega E; Kirienko A; Dzupina A; Sabovic M; Reina Gutierrez L; Subwongcharoen S; Tüzün H; Maggioli A
Int Angiol; 2017 Oct; 36(5):402-409. PubMed ID: 28206732
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of once-daily micronized purified flavonoid fraction 1000 mg tablet in patients with symptomatic chronic venous disease.
Kirienko A; Radak D; Maggioli A
Curr Med Res Opin; 2019 Mar; 35(3):553-557. PubMed ID: 29992831
[TBL] [Abstract][Full Text] [Related]
17. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
Ulloa JH
Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
[TBL] [Abstract][Full Text] [Related]
18. Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous Thrombosis: Results of a Pilot Clinical Trial.
Lobastov K; Schastlivtsev I; Barinov V
Adv Ther; 2019 Jan; 36(1):72-85. PubMed ID: 30539384
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of micronized purified flavonoid fraction (MPFF) in edema.
Olszewski W
Angiology; 2000 Jan; 51(1):25-9. PubMed ID: 10667640
[TBL] [Abstract][Full Text] [Related]
20. [Perioperative administration of micronized purified flavonoid fraction in endovascular treatment of varicose disease].
Bogachev VI; Boldin BV; Turkin PI
Angiol Sosud Khir; 2019; 25(2):88-95. PubMed ID: 31149994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
